A phase II study of trastuzumab and capecitabine for patients with HER2-overexpressing metastatic breast cancer: Japan Breast Cancer Research Network (JBCRN) 00 Trial

Daigo Yamamoto; Satoru Iwase; Kaoru Kitamura; Hiroki Odagiri; Chizuko Yamamoto; Yoshinori Nagumo

doi:10.1007/s00280-007-0497-5

A phase II study of trastuzumab and capecitabine for patients with HER2-overexpressing metastatic breast cancer: Japan Breast Cancer Research Network (JBCRN) 00 Trial

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-007-0497-5 ◽

2007 ◽

Vol 61 (3) ◽

pp. 509-514 ◽

Cited By ~ 34

Author(s):

Daigo Yamamoto ◽

Satoru Iwase ◽

Kaoru Kitamura ◽

Hiroki Odagiri ◽

Chizuko Yamamoto ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Research ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Breast Cancer Research ◽

Research Network ◽

Cancer Research Network

Download Full-text

Phase II study of docetaxel in combination with epirubicin and protracted venous infusion 5-fluorouracil (ETF) in patients with recurrent or metastatic breast cancer. A Yorkshire breast cancer research group study

British Journal of Cancer ◽

10.1038/sj.bjc.6601840 ◽

2004 ◽

Vol 90 (11) ◽

pp. 2131-2134 ◽

Cited By ~ 3

Author(s):

A C Humphreys ◽

J Dent ◽

S Rodwell ◽

S M Crawford ◽

J K Joffe ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Research ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Research Group ◽

Phase Ii Study ◽

Metastatic Breast ◽

Breast Cancer Research ◽

Venous Infusion

Download Full-text

A phase II study of medroxyprogesterone acetate in patients with hormone receptor negative metastatic breast cancer: translational breast cancer research consortium trial 007

Breast Cancer Research and Treatment ◽

10.1007/s10549-014-3131-3 ◽

2014 ◽

Vol 148 (1) ◽

pp. 99-106 ◽

Cited By ~ 9

Author(s):

Kathy D. Miller ◽

Sandra K. Althouse ◽

Lisle Nabell ◽

Hope Rugo ◽

Lisa Carey ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Research ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Medroxyprogesterone Acetate ◽

Hormone Receptor ◽

Phase Ii Study ◽

Metastatic Breast ◽

Breast Cancer Research ◽

Research Consortium

Download Full-text

A phase II study of medroxyprogesterone acetate (MPA) in patients (pts) with hormone receptor-negative (HR-) metastatic breast cancer (MBC): Translational Breast Cancer Research Consortium trial 007.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.1074 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 1074-1074

Author(s):

L. G. Vaughn ◽

L. Li ◽

L. Nabell ◽

H. S. Rugo ◽

L. A. Carey ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Research ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Medroxyprogesterone Acetate ◽

Hormone Receptor ◽

Phase Ii Study ◽

Metastatic Breast ◽

Breast Cancer Research ◽

Research Consortium

Download Full-text

Paclitaxel and Mitoxantrone in the Treatment of Metastatic Breast Cancer: A Phase II Trial of the Minnie Pearl Cancer Research Network

Cancer Investigation ◽

10.1081/cnv-120005897 ◽

2002 ◽

Vol 20 (7-8) ◽

pp. 863-871 ◽

Cited By ~ 1

Author(s):

John D. Hainsworth ◽

Sharon Calvert ◽

F. Anthony Greco

Keyword(s):

Breast Cancer ◽

Cancer Research ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Research Network ◽

Cancer Research Network

Download Full-text

A Cancer Research (UK) randomized phase II study of idoxifene in patients with locally advanced/metastatic breast cancer resistant to tamoxifen

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-003-0733-6 ◽

2004 ◽

Vol 53 (4) ◽

pp. 341-348 ◽

Cited By ~ 13

Author(s):

L. A. Gumbrell ◽

T. R. J. Evans ◽

R. E. Coleman ◽

I. E. Smith ◽

C. J. Twelves ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Research ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Metastatic Breast ◽

Randomized Phase Ii

Download Full-text

Pegylated Liposomal Doxorubicin (Doxil®) for Metastatic Breast Cancer: The Cancer Research Network, Inc., Experience

Cancer Investigation ◽

10.1081/cnv-120014883 ◽

2002 ◽

Vol 20 (sup2) ◽

pp. 22-29 ◽

Cited By ~ 72

Author(s):

Alejandra T. Perez ◽

Gabriel H. Domenech ◽

Cynthia Frankel ◽

Charles L. Vogel

Keyword(s):

Breast Cancer ◽

Cancer Research ◽

Metastatic Breast Cancer ◽

Liposomal Doxorubicin ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

Research Network ◽

Cancer Research Network

Download Full-text

Docetaxel and Epirubicin as First-Line Treatment for Patients with Metastatic Breast Cancer: A Minnie Pearl Cancer Research Network Phase II Trial

Cancer Investigation ◽

10.1080/07357900600814060 ◽

2006 ◽

Vol 24 (5) ◽

pp. 469-473 ◽

Cited By ~ 7

Author(s):

John D. Hainsworth ◽

Denise A. Yardley ◽

David R. Spigel ◽

Anthony A. Meluch ◽

David Rinaldi ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Research ◽

Metastatic Breast Cancer ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Research Network ◽

Line Treatment ◽

First Line ◽

Cancer Research Network ◽

First Line Treatment

Download Full-text

Safety of Herceptin monotherapy administered on a 3-weekly schedule: Preliminary data from a phase II study in women with HER2-positive metastatic breast cancer

European Journal of Cancer ◽

10.1016/s0959-8049(02)80299-4 ◽

2002 ◽

Vol 38 (11) ◽

pp. S95

Author(s):

J Baselga

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Preliminary Data ◽

Phase Ii Study ◽

Metastatic Breast ◽

Weekly Schedule ◽

Her2 Positive

Download Full-text

Randomised Phase II Study of Palbociclib Plus Exemestane with GnRH Agonist Versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer

SSRN Electronic Journal ◽

10.2139/ssrn.3414442 ◽

2019 ◽

Author(s):

Yeon Hee Park ◽

Tae-Yong Kim ◽

Gun Min Kim ◽

Kyung Hae Jung ◽

Seok Yun Kang ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Gnrh Agonist ◽

Hormone Receptor ◽

Phase Ii Study ◽

Metastatic Breast ◽

Premenopausal Women ◽

Hormone Receptor Positive

Download Full-text

Phase II Study of Dehydroepiandrosterone in Androgen Receptor‐Positive Metastatic Breast Cancer

The Oncologist ◽

10.1634/theoncologist.2018-0243 ◽

2018 ◽

Vol 24 (6) ◽

pp. 743 ◽

Cited By ~ 1

Author(s):

Elisabetta Pietri ◽

Ilaria Massa ◽

Sara Bravaccini ◽

Sara Ravaioli ◽

Maria Maddalena Tumedei ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Androgen Receptor ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast

Download Full-text